NovaDel Announces Clinical Development Strategy to Advance Candidates With Near-term NDA Submissions

NovaDel Pharma Inc. announced a refined clinical development strategy focused on advancing its most mature drug candidates to New Drug Applications (NDAs) with the Food and Drug Administration (FDA).
Novadel